TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
TENX

Tenax Therapeutics Inc

Healthcare · Biotechnology

2.00$ +2.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement TENX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% – – – – – – – – – –
263.4% 19.7% – – – – – – – – – –
100.0% 80.3% – – – – – – – – – –
13,513.8% 13,513.8% – – – – – – – – – –
14,549.3% 14,549.3% – – – – – – – – – –
30,162.8% 28,063.1% – – – – – – – – – –
-27,775.2% -31,729.6% – – – – – – – – – –
99.6% 99.6% – – – – – – – – – –
-28,571.6% -30,641.5% – – – – – – – – – –
1,457.7% 509.0% – – – – – – – – – –
-28,571.6% -28,571.6% – – – – – – – – – –
-28,171.5% -31,634.6% – – – – – – – – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?